Rotavirus VP4: Structure and function

描述（由申请人提供）：每年，轮状病毒胃肠炎在全世界造成约600，000名儿童死亡，并在美国使约60，000名儿童住院。由于轮状病毒疫苗被撤回，它再次成为一种主要的儿童疾病，无法进行免疫接种。轮状病毒进入细胞的过程是疾病干预的主要目标。为了启动感染，轮状病毒将一个大的转录活性颗粒穿过膜转移到细胞质中。无包膜轮状病毒颗粒的外层是完成这种知之甚少的易位的递送装置。外衣壳含有两种蛋白质，VP7和VP4，这两种蛋白质都积极参与进入，并且是中和抗体的靶标。VP7导致钙流失时脱膜。VP4是一种刺突蛋白，被胰蛋白酶切割，使病毒感染。VP4是膜渗透机制的核心。它包含一个头部结构域和一个膜相互作用结构域。我们纯化了未切割的VP4，用蛋白酶引发纯化的蛋白质，确定了头部结构域的结构，并结晶了膜相互作用结构域的引发形式。使用这些晶体，我们将解决膜相互作用域的引发构象的结构。该结构将用于改进VP4未切割构象的结构分析策略。我们还将确定功能上重要的VP4变体的结构。我们已经开发了一种用于轮状病毒的“重包被遗传学”系统，通过用纯化的重组VP4和VP7重包被亚病毒颗粒，将感染性提高4到5个数量级。该系统将允许分析工程化突变（包括基于结构的突变）在细胞进入期间对VP4功能的影响。突变研究将阐明唾液酸依赖性、蛋白酶引发和膜渗透的决定因素。使用重包被颗粒的基于细胞培养的测定将集中于使用基于结构的突变在进入期间分离碳水化合物、脂质和蛋白质结合，以及通过引入可逆二硫键交联来阻断进入相关的构象变化。这些结构和功能研究将阐明轮状病毒进入途径，提供无包膜病毒进入的模型，并确定轮状病毒中和VP4抗体的结构基础。

DESCRIPTION (provided by applicant): Each year, rotavirus gastroenteritis kills an estimated 600,000 children, worldwide, and hospitalizes approximately 60,000 children, in the U.S. Since the withdrawal of a rotavirus vaccine, it is again a major childhood illness for which no immunization is available. The process of cell entry by rotavirus is a major target for intervention against disease. To initiate infection, rotavirus translocates a large, transcriptionally active particle across a membrane and into the cytoplasm. The outer layer of the non-enveloped rotavirus particle is the delivery apparatus that accomplishes this poorly understood translocation. The outer capsid contains two proteins, VP7 and VP4, both of which participate actively in entry and are targets of neutralizing antibodies. VP7 causes uncoating on loss of calcium. VP4, a spike protein, is cleaved by trypsin to prime the virus for infection. VP4 is central to the mechanism of membrane penetration. It contains a head domain and a membrane interaction domain. We have purified uncleaved VP4, primed the purified protein with protease, determined the structure of the head domain, and crystallized the primed form of the membrane interaction domain. Using these crystals, we will solve the structure of the primed conformation of the membrane interaction domain. This structure will be used to refine strategies for the structural analysis of the uncleaved conformation of VP4. We will also determine the structures of functionally important VP4 variants. We have developed a "recoating genetics" system for rotavirus by recoating subviral particles with purified, recombinant VP4 and VP7, boosting infectivity by 4 to 5 orders of magnitude. This system will allow analysis of the effect of engineered mutations, including structure-based mutations, on the function of VP4 during cell entry. Mutational studies will clarify the determinants of sialic acid-dependence, protease priming, and membrane penetration. Cell culture-based assays using recoated particles will focus on separating carbohydrate, lipid, and protein binding during entry using structure-based mutations and on blocking entry-associated conformational changes by introducing reversible disulfide cross-links. These structural and functional studies will clarify the rotavirus entry pathway, provide a model for entry by non-enveloped viruses, and define the structural basis for rotavirus neutralization by antibodies against VP4.